IL6 and metabolic disease: The aggravation of oxidative stress not only stimulates the release of IFN-γ from macrophages, but also induces the secretion of inflammatory factors such as IL-6 and IL-1β, ultimately leading to metabolic disorders in the intestinal mucosa.